01 · SignalFirst read of a biological signal.
We start from human evidence. Mechanism papers may inspire the question, but only outcome trials in real bodies move us forward.
The science
Evidence over claims.
Four biological levers. A three-stage editorial filter. One protocol that earns its place — measurable in twenty-eight days.
No proprietary blends · No marketing complexes · Open dosing
Editorial review desk · Sofia · routine batch and dose verification.
The charter
We publish what we can defend.
Every recommendation passes a slow, manual review. We start from human evidence, hold dosing to label, and refuse blends that obscure the chemistry. The protocol is the smallest set that earns its place — nothing more.
01
Dose discipline
Active doses appear on the label. No proprietary complexes, no rounded marketing figures.
02
Batch verification
Independent assays for actives, heavy metals and microbial load before any batch is released.
03
No proprietary blends
If a synergist is present, it is named and weighed. The chemistry is yours to audit.
04
EU-tested supply
Sourced and assayed inside the European regulatory framework, with traceable batch records.
Mechanisms
Four levers — measured, not assumed.
We do not optimise for everything. Each module targets one of the four levers below, sized to the depth your protocol calls for.
01 · NAD pathway · mitochondrial output
Cellular energy
Restore the cell's working currency. The NAD pathway sets the ceiling for energy availability, repair pressure, and metabolic recovery.
How we filter
Three slow stages.
Nothing reaches the catalogue without passing all three. The stages run in order — and the answer at any stage can be "no."
01 · Signal02 · ScreenEvidence and dose review.
If the signal holds, formulation is screened against label dosing, third-party assays and supply chain transparency. Rounded figures fail.
03 · IntegratePlacement into a daily rhythm.
Surviving candidates earn a place in a stack only when they integrate cleanly with cadence, food and the existing protocol weight.
We say no more often than yes.
Most candidates fall at the screen. The catalogue is small because the filter is slow — and the slow filter is the product.
What changes
What this gets you.
An editorial filter is not a luxury. It is the difference between a shelf you trust and a shelf you have to second-guess.
01
A ranked starting point.
The intake returns the smallest stack that addresses what was measured — not the broadest one we could sell.
02
A smaller, more disciplined set.
Fewer SKUs in your routine. Each one accountable to a measurable lever, not a category trend.
03
A clearer next step.
When the twenty-eight-day window closes, the next move is obvious — keep, step up, or remove. No theatre.
Where to begin
Take the protocol intake.
A short, clinically structured questionnaire returns the smallest stack — and the right tier — that addresses the biological levers measured.